Recent SEC filings
Insider and ownership filing tracker
Form 4 reports insider transactions. Schedule 13D and 13G filings report certain significant ownership positions. 13F reports institutional holdings when filed by an investment manager. Always open the original filing for context.
Company and financial overview
This is a data-generated overview, not a published Rithvik Chethan research rating. Figures use the latest usable company filing and may differ from vendor-calculated trailing metrics.
Financial performance charts
Annual values from SEC filings. Free cash flow is calculated as operating cash flow less capital expenditures.
Upcoming catalyst timeline
Review the Earnings tab for the expected date and estimates.
FORM 8-K
EMA, RSI, MACD, volume, structure, and key levels update after a completed daily candle.
How the research score works
The overall score is a weighted research judgment covering business quality, fundamental strength, growth catalysts, valuation, technical condition, and downside risk. A high score does not eliminate risk, and a low score does not guarantee poor performance.
Company overview
3M is a diversified industrial and consumer products company with a broad portfolio spanning safety and industrial products, transportation and electronics, and consumer goods, following the spinoff of its healthcare business into a separate company.
Business model
The company earns revenue from a highly diversified product portfolio across thousands of applications, with its scientific research and manufacturing capabilities historically supporting continuous new product development across its business segments.
Growth drivers
- Portfolio simplification improving management focus following the healthcare spinoff
- New product innovation across its industrial and consumer categories
- Cost efficiency initiatives improving margins
- International market growth in core industrial categories
Competitive position
3M's diversified technology platforms and manufacturing scale give it a broad competitive position across many industrial and consumer categories, though the company has faced execution challenges and significant legal liabilities in recent years.
Risks
Significant legal settlements related to environmental and product liability matters have weighed on the company's financial flexibility, industrial demand cycles affect various segments differently, and continued execution on portfolio simplification carries ongoing risk.
Valuation
3M trades at a discounted multiple relative to other diversified industrials, reflecting the legal overhang and execution uncertainty that has affected investor sentiment in recent years.
Final view
3M's portfolio simplification following its healthcare spinoff represents a step toward a cleaner investment story, though legal liabilities remain a lingering overhang. My view is cautious, with continued resolution of legal matters and margin improvement being key things to track.
Overall rating: 59/100
This website and its analysis are provided for educational and informational purposes only. Nothing on this site constitutes financial, investment, legal, or tax advice, or an offer to buy or sell any security. Market data is provided by Finnhub and other third-party sources and may be delayed, incomplete, or inaccurate. The author may hold positions in securities discussed, and opinions may change without notice. Past performance does not guarantee future results. Always conduct your own research and consult a qualified financial professional before making investment decisions.